Calamos Strategic Total Return Fund - Closed End Fund (NQ:CSQ)

19.86 +0.11 (+0.56%)

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Calamos Strategic Total Return Fund - Closed End Fund

Why a Major Investor Dumped $32 Million of This 7.2% Yielding Closed-End Fund ↗

May 09, 2026

The Calamos Strategic Total Return Fund blends equities and fixed income, aiming for balanced returns through a multi-asset approach.

Via The Motley Fool

Topics Bonds Regulatory Compliance

Shaker Financial Offloads $3.3 Million CSQ Shares, According to Recent SEC Filing ↗

January 28, 2026

This closed-end fund targets total return through a diversified mix of U.S. equities and fixed income securities.

Via The Motley Fool

Topics Bonds Regulatory Compliance

Shaker Financial Offloads $3.3 Million CSQ Shares, According to Recent SEC Filing ↗

January 27, 2026

This closed-end fund targets total return through a diversified mix of U.S. equities and fixed income securities.

Via The Motley Fool

Topics Bonds Regulatory Compliance

Calamos Strategic Total's Ex-Dividend Date Is Monday, Here's What You Need To Know ↗

December 06, 2023

Via Benzinga

Calamos Strategic Total's Ex-Dividend Date Is Thursday, Here's What You Need To Know ↗

May 08, 2023

Via Benzinga

Friday Is Your Last Chance To Buy Calamos Strategic Total Before The Dividend Payout ↗

March 08, 2023

Via Benzinga

The 3 Best Closed-End Funds to Buy in May at a Discount ↗

May 28, 2024

Closed-end funds don’t get as much attention as ETFs and mutual funds. However, they often trade at a discount, so they’re worth a look.

Via InvestorPlace

Topics ETFs

Tuesday Is Your Last Chance To Buy Calamos Strategic Total Before The Dividend Payout ↗

March 08, 2024

Via Benzinga

Wednesday Is Your Last Chance To Buy Calamos Strategic Total Before The Dividend Payout ↗

December 25, 2023

Via Benzinga

Wednesday Is Your Last Chance To Buy Calamos Strategic Total Before The Dividend Payout ↗

October 10, 2022

Wednesday marks the last chance for investors to receive the next dividend payout from Calamos Strategic Total (NASDAQ:CSQ).

Via Benzinga

Friday Is Your Last Chance To Buy Calamos Strategic Total Before The Dividend Payout ↗

September 07, 2022

Friday marks the last chance for investors to receive the next dividend payout from Calamos Strategic Total (NASDAQ:CSQ).

Via Benzinga

Calamos Strategic Total's Ex-Dividend Date Is Tuesday, Here's What You Need To Know ↗

July 07, 2022

Monday marks the last chance for investors to receive the next dividend payout from Calamos Strategic Total (NASDAQ:CSQ).

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

April 16, 2021

Friday's morning session saw 420 companies set new 52-week highs. Intriguing Points: The largest company by market cap to set a new 52-week high was Microsoft (...

Via Benzinga

Stocks That Hit 52-Week Highs On Thursday ↗

April 15, 2021

Thursday morning saw 166 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to hit a new 52-week high was Microsoft (NASDAQ:...

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

April 09, 2021

During the morning session on Friday, 178 stocks hit new 52-week highs. Noteworthy Points: Microsoft (NASDAQ:MSFT) was the largest firm on a market cap basis to set...

Via Benzinga

Stocks That Hit 52-Week Highs On Wednesday ↗

April 07, 2021

This morning 134 companies reached new 52-week highs. Facts of Interest: Alphabet (NASDAQ:GOOG) was the largest firm on a market cap basis to set a new 52-week high....

Via Benzinga

Calamos Strategic Total: Dividend Insights ↗

April 07, 2022

Monday marks the last chance for investors to receive the next dividend payout from Calamos Strategic Total (NASDAQ:

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.